Antibody responses to second doses of COVID-19 vaccination in lung cancer patients undergoing treatment

BACKGROUND: Several reports have revealed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection tends to have more severe outcomes in cancer patients. Although vaccination reduces the risk of severe disease, data on antibody titers achieved by vaccination is scarce in cancer pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Narita, Daisuke, Ebina-Shibuya, Risa, Miyauchi, Eisaku, Tsukita, Yoko, Saito, Ryota, Murakami, Koji, Kimura, Nozomu, Sugiura, Hisatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. on behalf of The Japanese Respiratory Society. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750888/
https://www.ncbi.nlm.nih.gov/pubmed/36567161
http://dx.doi.org/10.1016/j.resinv.2022.11.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750888/
https://www.ncbi.nlm.nih.gov/pubmed/36567161
http://dx.doi.org/10.1016/j.resinv.2022.11.005

Ejemplares similares